|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 17, 2004.
Revised July 29, 2004.
Accepted for publication August 18, 2004.
12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes
The cyclopentenone prostaglandin (cyPG) and PPAR
agonist 15-deoxy-
12,14-prostaglandin J2 (15d-PGJ2) displays anti-inflammatory effects in several experimental models. Direct modification of protein thiols is arising as an important mechanism of cyPG action. However, little is known about the extent or specificity of this process. Mesangial cells (MC) play a key role in glomerulonephritis. Here we have studied the selectivity of protein modification by 15d-PGJ2 in MC, and the correlation with the modulation of several pro-inflammatory genes. MC incubation with biotinylated 15d-PGJ2 results in the labeling of a distinct set of proteins as evidenced by 2D-electrophoresis. 15d-PGJ2 binds to nuclear and cytosolic targets as detected by fluorescence microscopy and subcellular fractionation. The pattern of biotinylated 15d-PGJ2-modified polypeptides is readily distinguishable from that of total protein staining or labeling with biotinylated iodoacetamide. 15d-PGJ2 addition requires the double bond in the cyclopentane ring. 9,10-dihydro-15d-PGJ2, a 15d-PGJ2 analog that shows the same potency as PPAR agonist in MC but lacks the cyclopentenone moiety, displays reduced ability to modify proteins and to block 15d-PGJ2 binding. Micromolar concentrations of 15d-PGJ2 inhibit cytokine-elicited levels of inducible nitric oxide synthase, cyclooxygenase-2 and intercellular adhesion molecule-1 in MC. In contrast, 9,10-dihydro-15d-PGJ2 does not reproduce this inhibition. 15d-PGJ2 effect is not blocked by the PPAR
antagonist GW9662. Moreover, compounds possessing an
,
-unsaturated carbonyl group, like 2-cyclopenten-1-one and 2-cyclohexen-1-one, reduce pro-inflammatory gene expression. These observations indicate that covalent modification of cellular thiols by 15d-PGJ2 is a selective process which plays an important role in the inhibition of MC responses to pro-inflammatory stimuli.
Key words:
Prostanoid, PPARs, Structure/function/mechanism, Cyclooxygenases, Eicosanoids
This article has been cited by other articles:
![]() |
A. J. Ryan, B. B. Chen, P. R. Vennalaganti, F. C. Henderson, L. A. Tephly, A. B. Carter, and R. K. Mallampalli 15-Deoxy-{Delta}12,14-prostaglandin J2 Impairs Phosphatidylcholine Synthesis and Induces Nuclear Accumulation of Thiol-modified Cytidylyltransferase J. Biol. Chem., September 5, 2008; 283(36): 24628 - 24640. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sandig, J. E. Pease, and I. Sabroe Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu, P. A. Egner, J. Wakabayashi, N. Wakabayashi, M. Yamamoto, and T. W. Kensler Nrf2-mediated Induction of Cytoprotective Enzymes by 15-Deoxy-{Delta}12,14-Prostaglandin J2 Is Attenuated by Alkenal/one Oxidoreductase J. Biol. Chem., September 8, 2006; 281(36): 26245 - 26252. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stamatakis, F. J. Sanchez-Gomez, and D. Perez-Sala Identification of Novel Protein Targets for Modification by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Mesangial Cells Reveals Multiple Interactions with the Cytoskeleton J. Am. Soc. Nephrol., January 1, 2006; 17(1): 89 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiraki, N. Kamiya, S. Shiki, T. S. Kodama, A. Kakizuka, and H. Jingami {alpha},{beta}-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor {gamma} J. Biol. Chem., April 8, 2005; 280(14): 14145 - 14153. [Abstract] [Full Text] [PDF] |
||||